Susquehanna International Group’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.1K | Sell |
19,945
-20,350
| -51% | -$47K | ﹤0.01% | 6046 |
|
|
2025
Q1 | $315K | Buy |
40,295
+16,800
| +72% | +$131K | ﹤0.01% | 4971 |
|
|
2024
Q4 | $110K | Buy |
+23,495
| New | +$110K | ﹤0.01% | 5647 |
|
|
2024
Q3 | – | Sell |
-42,772
| Closed | -$377K | – | 6058 |
|
|
2024
Q2 | $377K | Sell |
42,772
-112,062
| -72% | -$988K | ﹤0.01% | 3903 |
|
|
2024
Q1 | $1.82M | Buy |
154,834
+110,998
| +253% | +$1.3M | ﹤0.01% | 1936 |
|
|
2023
Q4 | $494K | Buy |
43,836
+11,995
| +38% | +$135K | ﹤0.01% | 3881 |
|
|
2023
Q3 | $218K | Sell |
31,841
-9,170
| -22% | -$62.7K | ﹤0.01% | 4446 |
|
|
2023
Q2 | $372K | Sell |
41,011
-29,626
| -42% | -$269K | ﹤0.01% | 3993 |
|
|
2023
Q1 | $456K | Buy |
70,637
+56,343
| +394% | +$364K | ﹤0.01% | 3939 |
|
|
2022
Q4 | $90.6K | Sell |
14,294
-9,479
| -40% | -$60.1K | ﹤0.01% | 4992 |
|
|
2022
Q3 | $147K | Buy |
+23,773
| New | +$147K | ﹤0.01% | 5038 |
|
|
2022
Q2 | – | Sell |
-52,042
| Closed | -$438K | – | 6222 |
|
|
2022
Q1 | $438K | Sell |
52,042
-38,536
| -43% | -$324K | ﹤0.01% | 3871 |
|
|
2021
Q4 | $924K | Buy |
90,578
+8,049
| +10% | +$82.1K | ﹤0.01% | 2970 |
|
|
2021
Q3 | $1.6M | Buy |
82,529
+6,815
| +9% | +$132K | ﹤0.01% | 2182 |
|
|
2021
Q2 | $1.33M | Buy |
75,714
+42,642
| +129% | +$749K | ﹤0.01% | 2594 |
|
|
2021
Q1 | $393K | Buy |
+33,072
| New | +$393K | ﹤0.01% | 4096 |
|
|
2020
Q2 | – | Sell |
-11,443
| Closed | -$38K | – | 4557 |
|
|
2020
Q1 | $38K | Buy |
+11,443
| New | +$38K | ﹤0.01% | 4255 |
|